Nicola Gaynor

Statistics

Publications

Citations

118

H-Index

Active since

2018

Affiliations

St. Vincent's University Hospital(Current)

Dublin City University

University College Dublin

Trinity College Dublin

Royal College of Surgeons in Ireland

Nicola Gaynor is an author at St. Vincent's University Hospital specializing in tyrosine kinase inhibitors, her2-positive breast cancer, and her2-positive breast cancer therapy.

Publications per year

2018–2023

Publications

Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer

Denis M. Collins, Stephen F. Madden, Nicola Gaynor et al. · Clinical Cancer Research · 2020 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17

HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer

Alexandra Canonici, Laura Ivers, Neil T. Conlon et al. · Investigational New Drugs · 2018 · 29 citations

Medicine, Oncology, Pharmacology +14

Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy

Nicola Gaynor, Alfonso Blanco, Stephen F. Madden et al. · British Journal of Cancer · 2023 · 13 citations · Full text

Medicine, Immunology, Oncology +17

1–3 of 3